Thermo Fisher Scientific Inc
Research Thermo Fisher Scientific Inc (TMO) on Bullrun: valuation model: 6.9% overvalued, market cap USD 232.26B, P/E 33.8, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTMO
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal6.9% overvalued
- Market capUSD 232.26B
- P/E33.8
- Dividend yield0.3%
- Financial periodQ2 2026
- RevenueUSD 11.99B
- Net incomeUSD 1.74B
- Free cash flowUSD 1.68B
- Gross margin40.7%
Valuation Snapshot
Bullrun's latest valuation model marks Thermo Fisher Scientific Inc as 6.9% overvalued; latest market cap is USD 232.26B; P/E is 33.8; dividend yield is 0.3%.
Peer valuation comparison
Latest P/E is 33.79x versus a Healthcare sector median of 24.46x (38.1% above).
Latest dividend yield is 0.29% versus a Healthcare sector median of 2.11% (86.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 44.56B | USD 6.72B | USD 6.29B | 40.9% | 17.74 | USD 9.85B | USD 42.71B | USD 53.41B |
| FY2024 | USD 42.88B | USD 6.34B | USD 7.27B | 41.3% | 16.53 | USD 4.01B | USD 33.29B | USD 49.58B |
| FY2023 | USD 42.86B | USD 5.96B | USD 6.93B | n/a | 15.45 | USD 8.08B | USD 38.34B | USD 46.74B |
| FY2022 | USD 44.92B | USD 6.96B | USD 6.91B | n/a | 17.63 | USD 8.52B | USD 39.86B | USD 43.98B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 232.26B | 33.8 | 0.3% | 1.8 |
| 2025 | 2025-12-31 | USD 218.00B | 32.7 | 0.3% | 1.72 |
| 2024 | 2024-12-31 | USD 198.09B | 31.5 | 0.3% | 1.56 |
| 2023 | 2023-12-29 | USD 205.08B | 34.8 | 0.3% | 1.4 |
| 2022 | 2022-12-30 | USD 215.98B | 31.0 | 0.2% | 1.2 |
| 2021 | 2021-12-31 | USD 263.18B | 34.3 | 0.2% | 1.04 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.8 USD, yield 0.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.72 USD |
| FY2024 | 1.56 USD |
| FY2023 | 1.4 USD |
| FY2022 | 1.2 USD |
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Thermo Fisher Scientific Inc overvalued or undervalued?
Bullrun's valuation model currently marks Thermo Fisher Scientific Inc as 6.9% overvalued.
What is Thermo Fisher Scientific Inc's market cap?
Thermo Fisher Scientific Inc's market capitalization is USD 232.26B.
What is Thermo Fisher Scientific Inc's P/E ratio?
Thermo Fisher Scientific Inc's price-to-earnings (P/E) ratio is 33.8.
Does Thermo Fisher Scientific Inc pay a dividend?
Thermo Fisher Scientific Inc has a dividend yield of 0.3%.
What does Thermo Fisher Scientific Inc do?
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases.